Halleran–Voss Halleran–Voss
HALLERAN–VOSS Pharmaceuticals a Civic Chemical company
EST. 1946
NYSE: HLV
CONTRACT 4471-B

Future medicine for present conditions.

Materials released in the public interest, 1946–2036. What follows is the current preparation index. Prescribing information is abbreviated; full particulars are supplied to licensed institutions and to contracted authorities on request.

Certified Civic Supplier · Class II Office of Domestic Compliance
Civic Health Accord, 25 August 2036
reviewed annually


About Halleran–Voss

Ninety years of asking what a patient needs. We are now also a company that asks what the country needs, and we regard the second question as an extension of the first rather than a departure from it.

Incorporated
1946 · Wilmington, Delaware
Parent
Civic Chemical Corporation, since 1971
Employees
14,200
Listing
NYSE: HLV
Federal contract
4471-B · reviewed annually

The company

Halleran–Voss was incorporated in 1946 as a manufacturer of sedative and antihistamine preparations for the domestic market, and has been a subsidiary of Civic Chemical since 1971. For most of that history the company served physicians. It now serves physicians and the institutions that employ them.

The Civic Health Accord

On 25 August 2036 the company entered a long-term partnership with the Office of Domestic Compliance — the first agreement of its kind between an American manufacturer and a federal agency of public order. One supply chain now runs from our laboratories to the Office’s field operations.

Adherence therapeutics

Much of what the Office now manages is behavioural rather than criminal. We believe those limits are, in substantial part, a medical problem, and therefore ours to address. The category comprises compounds intended to relieve the distress that accompanies civic friction — in the individual and in the community — without recourse to confinement.

Civic devices

Not every indication is answered by a compound. Our devices division supplies SYNCORE, a cortical pacing implant fitted at employer request for pace deficit in retained staff following automation of adjacent functions. The implant does not increase capability. It suppresses the signal that work has been completed, which in the great majority of wearers is sufficient. The device is not removable; this is the basis of the productivity guarantee.

Civic engagement

Halleran–Voss is a founding underwriter of the Continuity Caucus, a new direction for the party of order. The company does not take positions on legislation. It supports the conditions under which legislation can be enacted without interruption.

Regulatory

Preparations in the adherence category are authorised by the Office under Class II civic supply and are not subject to the ordinary retail approval pathway. Availability varies by class. Several preparations are supplied only to contracted authorities, and are not available by prescription.

Our obligation is to the public interest, and the public interest is expressed through its institutions.

Charles E. HalleranPresident and Chief Executive Officer